Walgreens Boots Alliance (NASDAQ:WBA) PT Lowered to $10.00 at Evercore ISI

Walgreens Boots Alliance (NASDAQ:WBA) had its target price decreased by Evercore ISI from $17.00 to $10.00 in a research note released on Friday, Benzinga reports. Evercore ISI currently has an in-line rating on the pharmacy operator’s stock.

A number of other equities research analysts have also weighed in on the company. Truist Financial reaffirmed a hold rating and set a $25.00 target price on shares of Walgreens Boots Alliance in a research report on Monday, April 1st. TD Cowen reduced their price target on Walgreens Boots Alliance from $37.00 to $35.00 and set a buy rating for the company in a research report on Wednesday, April 3rd. UBS Group reduced their price target on Walgreens Boots Alliance from $22.00 to $17.00 and set a neutral rating for the company in a research report on Monday, June 24th. Raymond James reissued a market perform rating on shares of Walgreens Boots Alliance in a research report on Tuesday, March 26th. Finally, Deutsche Bank Aktiengesellschaft dropped their target price on Walgreens Boots Alliance from $23.00 to $22.00 and set a hold rating on the stock in a research note on Wednesday, April 3rd. Four equities research analysts have rated the stock with a sell rating, eleven have assigned a hold rating and two have given a buy rating to the company. According to data from MarketBeat.com, the company presently has an average rating of Hold and a consensus price target of $20.64.

Walgreens Boots Alliance Price Performance

Shares of WBA stock opened at $12.10 on Friday. Walgreens Boots Alliance has a 52-week low of $11.68 and a 52-week high of $31.32. The company has a debt-to-equity ratio of 0.49, a quick ratio of 0.32 and a current ratio of 0.65. The firm has a market capitalization of $10.44 billion, a P/E ratio of -1.80, a P/E/G ratio of 0.84 and a beta of 0.78. The stock has a 50 day moving average price of $16.49 and a 200 day moving average price of $20.14.

Walgreens Boots Alliance (NASDAQ:WBA) last issued its quarterly earnings results on Thursday, June 27th. The pharmacy operator reported $0.63 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.68 by ($0.05). Walgreens Boots Alliance had a positive return on equity of 12.63% and a negative net margin of 3.99%. The business had revenue of $36.40 billion for the quarter, compared to the consensus estimate of $35.94 billion. During the same period in the prior year, the business posted $1.00 earnings per share. Walgreens Boots Alliance’s revenue was up 2.8% on a year-over-year basis. As a group, sell-side analysts predict that Walgreens Boots Alliance will post 2.94 earnings per share for the current year.

Walgreens Boots Alliance Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Wednesday, June 12th. Stockholders of record on Tuesday, May 21st were paid a $0.25 dividend. The ex-dividend date of this dividend was Monday, May 20th. This represents a $1.00 dividend on an annualized basis and a dividend yield of 8.26%. Walgreens Boots Alliance’s payout ratio is -14.84%.

Insider Transactions at Walgreens Boots Alliance

In related news, CFO Manmohan Mahajan bought 6,000 shares of the stock in a transaction dated Tuesday, April 2nd. The shares were purchased at an average price of $19.38 per share, for a total transaction of $116,280.00. Following the completion of the purchase, the chief financial officer now directly owns 166,969 shares of the company’s stock, valued at $3,235,859.22. The purchase was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. In other Walgreens Boots Alliance news, Director Inderpal S. Bhandari purchased 3,000 shares of Walgreens Boots Alliance stock in a transaction that occurred on Thursday, April 11th. The stock was bought at an average price of $18.05 per share, with a total value of $54,150.00. Following the acquisition, the director now owns 3,000 shares of the company’s stock, valued at approximately $54,150. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CFO Manmohan Mahajan purchased 6,000 shares of Walgreens Boots Alliance stock in a transaction that occurred on Tuesday, April 2nd. The stock was acquired at an average cost of $19.38 per share, with a total value of $116,280.00. Following the acquisition, the chief financial officer now directly owns 166,969 shares in the company, valued at approximately $3,235,859.22. The disclosure for this purchase can be found here. Company insiders own 17.40% of the company’s stock.

Hedge Funds Weigh In On Walgreens Boots Alliance

A number of hedge funds have recently made changes to their positions in WBA. Vanguard Group Inc. raised its holdings in shares of Walgreens Boots Alliance by 14.5% during the third quarter. Vanguard Group Inc. now owns 86,675,198 shares of the pharmacy operator’s stock valued at $1,927,656,000 after acquiring an additional 10,962,030 shares during the last quarter. Capital World Investors raised its holdings in shares of Walgreens Boots Alliance by 57.5% during the first quarter. Capital World Investors now owns 29,061,021 shares of the pharmacy operator’s stock valued at $630,334,000 after acquiring an additional 10,612,373 shares during the last quarter. Morgan Stanley raised its holdings in shares of Walgreens Boots Alliance by 15.8% during the third quarter. Morgan Stanley now owns 12,584,371 shares of the pharmacy operator’s stock valued at $279,876,000 after acquiring an additional 1,720,228 shares during the last quarter. Norges Bank acquired a new position in shares of Walgreens Boots Alliance during the fourth quarter valued at approximately $29,816,000. Finally, International Assets Investment Management LLC raised its holdings in shares of Walgreens Boots Alliance by 1,985.1% during the fourth quarter. International Assets Investment Management LLC now owns 889,546 shares of the pharmacy operator’s stock valued at $23,226,000 after acquiring an additional 846,884 shares during the last quarter. Institutional investors and hedge funds own 58.59% of the company’s stock.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.